Drugplain

Calcium Polycarbophil 625 mg/1

Calcium Polycarbophil · TABLET · CITRAGEN PHARMACEUTICALS, INC.

No Recall HistoryCurrently in Shortage
Plain English

Calcium Polycarbophil is a tablet containing calcium polycarbophil at 625 mg/1, taken oral. Manufactured by CITRAGEN PHARMACEUTICALS, INC..

Key Facts

Brand Name
Calcium Polycarbophil
Generic Name
Calcium Polycarbophil
NDC Code (Product)
70369-006
Manufacturer
CITRAGEN PHARMACEUTICALS, INC.
Strength
625 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
M007
Marketing Start
07/01/2025

Recall History

No Recall History

Frequently Asked Questions

What is Calcium Polycarbophil used for?

Calcium Polycarbophil contains Calcium Polycarbophil. It is a tablet taken oral. Consult your doctor for specific uses.

Is Calcium Polycarbophil a controlled substance?

Calcium Polycarbophil is not classified as a controlled substance by the DEA.

What is the generic name for Calcium Polycarbophil?

The generic name for Calcium Polycarbophil is Calcium Polycarbophil. There are 11 other brand versions of Calcium Polycarbophil.

What is the NDC code for Calcium Polycarbophil 625 mg/1?

The NDC (National Drug Code) for Calcium Polycarbophil 625 mg/1 is 70369-006, listed by CITRAGEN PHARMACEUTICALS, INC..